PGNYProgyny, Inc.
$34.84+87% 1Y
$34.84
$16.3052 weeks$34.84
Latest close: a new 52-week highNov 6, 2026what changed →
The business
How PGNY's business earns
Progyny, Inc. earns 45% on the capital it employs against an estimated 9.0% cost of capital.
45%
Return on invested capital · cost of capital 9.0% · 36 points above the estimated cost of capital
- Operating margin
- 9.4%
Operating margin · Healthcare Plans median 2.7% · 12 months to Sep 30, 2026
- Cash conversion
- 2.39×
Cash conversion · 4.08× a year ago · operating cash flow divided by operating profit after tax
- Share count, year on year
- −10%
Share count, year on year · fewer shares than a year ago
Operating margin by fiscal year
| Year | Operating margin |
|---|---|
| FY2020 | 2.4% |
| FY2021 | 6.5% |
| FY2022 | 3.0% |
| FY2023 | 5.7% |
| FY2024 | 5.8% |
| FY2025 | 6.6% |
Details›
- Gross margin12 months to Sep 30, 2026
- 25%
- Operating margin12 months to Sep 30, 2026
- 9.4%
- Net margin12 months to Sep 30, 2026
- 6.8%
- Free cash flow margin
- 13%
- R&D as % of revenue
- 0.92%
- Revenue, trailing twelve months
- $1.34B
- Free cash flow, trailing twelve months
- $180M
- Net income, trailing twelve months
- $91M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 45%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
On our screensFree cash flow yield of 5 to 30 percent